智通财经APP讯,泰达生物(08189)公布,于2025年4月25日,董事会决议建议采纳2025年股份奖励计划,并将根据已于2023年1月1日生效的经修订的《GEM上市规则》第23章执行。该计划须待公司股东于即将召开的股东大会上批准方可作实。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.